Diflomotecan
Diflomotecan Uses, Dosage, Side Effects, Food Interaction and all others data.
Diflomotecan is under investigation in clinical trial NCT00080015 (Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)).
Trade Name | Diflomotecan |
Generic | Diflomotecan |
Diflomotecan Other Names | Diflomotecan |
Type | |
Formula | C21H16F2N2O4 |
Weight | Average: 398.366 Monoisotopic: 398.107813329 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Diflomotecan